Beyond Weight Loss: GLP-1 Usage and Appetite Regulation in the Context of Eating Disorders and Psychosocial Processes

Isabel Krug, An Binh Dang, Jade Portingale, Yakun Li, Ying Qing Won, Antonio Cepeda-Benito, Ata Ghaderi · 2025

Read Beyond Weight Loss: GLP-1 Usage and Appetite Regulation in the Context of Eating Disorders and Psychosocial Processes by Isabel Krug, An Binh Dang, Jade Portingale, Yakun Li, Ying Qing Won, Antonio Cepeda-Benito, Ata Ghaderi (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12694361.txt.

Description

Isabel Krug and co-authors review what weight-loss drugs do to minds as well as bodies, in this 2025 paper. The drugs, GLP-1 receptor agonists, curb appetite and quiet food reward, which is the territory of eating disorders. The authors gather the evidence on behavior, emotion, and body image through a framework joining biology, psychology, and social context.

The drugs cut hunger and binge eating, hinting at help for binge-type disorders. For restrictive disorders the evidence is thin, and a suppressed appetite could feed rigid control and perfectionism. Emotional eating eased in the short term, but long-term mental safety is unknown. Fast weight loss can also scramble body perception, while social media glamorizes thinness around the drugs. Access gaps hit teenagers and marginalized groups hardest. The authors call for research designed with patients and for monitoring that treats the mind as part of the prescription.

Catalog record

CREATORIsabel Krug, An Binh Dang, Jade Portingale, Yakun Li, Ying Qing Won, Antonio Cepeda-Benito, Ata Ghaderi
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE73 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12694361

Browse the full library · About the Tower of Babel